S&P Global Ratings has assigned an "AA-" rating to Omaha-based Nebraska Medicine's $130.7 million of series 2016 bonds and $136.4 million of series 2016 bonds.
"The 'AA-' rating reflects our view of such factors as Nebraska Medicine's position as the premier academic medical center in the growing Omaha service area, strong operating margins, very good coverage and stable balance sheet," said S&P analyst Kevin Holloran.
The outlook is stable, reflecting S&P's view of Nebraska Medicine's strong credit fundamentals, solid business position and strengthening financial profile.